Syrris Celebrates Successful Flow and Automated Process Chemistry Seminars
News Jun 29, 2012
Syrris’ latest free flow chemistry and automated process chemistry seminars, held during May in Dinslaken, Germany, built on the success of previous events in Thailand and India, with scientists from across Europe declaring them extremely beneficial.
Delegates at the flow chemistry workshops discovered both theoretical and practical aspects of reaction optimization and the adaptation of established batch chemistry processes, taking advantage of the opportunity to acquire ‘hands-on’ experience of the technique.
Those attending the automated process chemistry seminar were able to learn about reaction calorimetry and new crystallization techniques that enable narrower particle size distributions and better selectivity of polymorphs.
Branka Kaludjerovic, a research associate at Vinča Institute of Nuclear Sciences, Serbia, said: “The Syrris staff were very helpful and the theory of automated batch chemistry linked very well with the practical work,” and experimental scientist Jolande Celis, from Huntsman Performance Products, Belgium, added: “There was a good balance between theory and practical; I enjoyed the demo sessions and having the chance to do things myself.”
Syrris will be holding further workshops in Brazil during August and Japan in October, with an event planned in the USA later in the year, ensuring that chemists worldwide can benefit from the Company’s extensive knowledge and experience.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE